CD38 and COVID-19: Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to those of other acute viral infections or live attenuated vaccines in humans (47–49).